GlassScriptPhysician profile
Fred L Talarico
NPI 1467569590
$3,189.02
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $947 · 2020: $290 · 2021: $285 · 2022: $417 · 2023: $638 · 2024: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $501.55 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.54 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $264.58 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $259.81 | 2019-2024 | Xarelto |
| Glaxosmithkline, LLC. | $212.97 | 2019-2024 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $199.27 | 2019-2024 | Linzess, Viberzi, Ubrelvy |
| Merck Sharp & Dohme LLC | $176.06 | 2021-2024 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $142.54 | 2021-2023 | |
| Amarin Pharma, INC. | $109.48 | 2019 | |
| Abiomed | $106.47 | 2022 | |
| Pfizer INC. | $104.19 | 2019-2024 | |
| Boston Scientific Corporation | $86.28 | 2019-2024 | Watchman Access System |
| Medicomp INC | $70.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $64.27 | 2023-2024 | Camzyos |
| Janssen Scientific Affairs, LLC | $56.99 | 2023-2024 | Xarelto |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $54.12 | 2023-2024 | Inpefa |
| Biotronik INC. | $47.89 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $41.62 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $40.74 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $37.14 | 2024 | Arcalyst |
| Exact Sciences Corporation | $32.53 | 2024 | Cologuard Collection Kit |
| Allergan, INC. | $25.54 | 2019 | |
| Philips North America LLC | $25.38 | 2023 | |
| Abbott Laboratories | $24.40 | 2022 | |
| Sanofi-Aventis U.S. LLC | $24.30 | 2023 | |
| Akcea Therapeutics, INC. | $23.83 | 2019 | |
| Novo Nordisk INC | $21.08 | 2023 | Ozempic |
| Amgen INC. | $20.94 | 2019 | |
| Bardy Diagnostics, INC. | $15.50 | 2022 | |
| Horizon Therapeutics Plc | $15.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Talarico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.